List of articles with "Alzheimer's"

CaringKind at Davos

CaringKind at Davos

United States New York Alzheimer's Blue Zones CaringKind
THC and Celecoxib Combination

THC and Celecoxib Combination

United States San Antonio Alzheimer's THC Celecoxib
Sleep and Alzheimer's

Sleep and Alzheimer's

USA San Francisco Alzheimer's Applied Cognition glymphatic system
NeuroSense Patent for Alzheimer's

NeuroSense Patent for Alzheimer's

United States Cambridge Alzheimer's NeuroSense PrimeC
SciNeuro and Novartis Team Up

SciNeuro and Novartis Team Up

USA Rockville Alzheimer's Novartis SciNeuro
Alzheimer's Joint Accreditation

Alzheimer's Joint Accreditation

USA Chicago Alzheimer's Dementia Care Joint Accreditation
PrimeC Safety Profile

PrimeC Safety Profile

USA Cambridge Alzheimer's NeuroSense PrimeC
AI for Early Alzheimer's

AI for Early Alzheimer's

USA AI Boston Alzheimer's Linus Health
Tazbentetol Breakthrough

Tazbentetol Breakthrough

USA Los Angeles Alzheimer's Spinogenix Tazbentetol
Leqembi Data Unveiled

Leqembi Data Unveiled

Eisai Leqembi Alzheimer's
Eisai's LEQEMBI Data Reveal Breakthroughs

Eisai's LEQEMBI Data Reveal Breakthroughs

Japan Tokyo Eisai Leqembi Alzheimer's
Eisai Presents E2814 Data

Eisai Presents E2814 Data

Japan Tokyo Eisai Alzheimer's Etalanetug
Tazbentetol Approved

Tazbentetol Approved

USA Los Angeles Alzheimer's Spinogenix Tazbentetol
Lighthouse Pharmaceuticals at CTAD 2025

Lighthouse Pharmaceuticals at CTAD 2025

United States San Diego Alzheimer's Lighthouse LHP588
LEQEMBI IQLIK FDA Submission

LEQEMBI IQLIK FDA Submission

Japan Tokyo Eisai Leqembi Alzheimer's
Semaglutide Trials

Semaglutide Trials

United States New York Alzheimer's Semaglutide Novo Nordisk
Akeso's Alzheimer's Breakthrough

Akeso's Alzheimer's Breakthrough

China Hong Kong Alzheimer's Akeso AK152
Pine Glo Memory Care

Pine Glo Memory Care

USA Alzheimer's Zebulon Pine Glo Reminiscents Project
Leqembi Approved in Canada

Leqembi Approved in Canada

Canada Stockholm Lecanemab Leqembi Alzheimer's
Dr. Fortea's Alzheimer's Research

Dr. Fortea's Alzheimer's Research

USA Washington Alzheimer's ApoE4 Dr. Fortea
Tau Aggregation Breakthrough

Tau Aggregation Breakthrough

Japan Tokyo Alzheimer's Tau Protein Precursor Cluster
LEQEMBI IQLIK™ Wins TIME Honor

LEQEMBI IQLIK™ Wins TIME Honor

Japan Tokyo Leqembi Alzheimer's IQLIK
NULISAqpcr™ BD-pTau217

NULISAqpcr™ BD-pTau217

USA Alzheimer's Fremont, California Alamar Biosciences NULISAqpcr
Neuraceq® Production Boost

Neuraceq® Production Boost

United States Alzheimer's Neuraceq Life Molecular Imaging Decatur, IL
Improving Alzheimer's Trials

Improving Alzheimer's Trials

Canada Toronto Alzheimer's Parkinson's Biomarkers
Leqembi Iqlik Launch

Leqembi Iqlik Launch

USA Stockholm Eisai Leqembi Alzheimer's
Leqembi® Approved

Leqembi® Approved

China Beijing Leqembi BioArctic Alzheimer's
Kisunla Approved

Kisunla Approved

None Alzheimer's Kisunla Donanemab
Gene Mutation and Alzheimer's

Gene Mutation and Alzheimer's

United States Alzheimer's Endeavor Health Evanston PICALM
Phase 2 Trial for ADP

Phase 2 Trial for ADP

USA San Francisco Alzheimer's ML-007C-MA MapLight
Etalanetug Fast Track

Etalanetug Fast Track

Japan Tokyo Eisai Alzheimer's Etalanetug
Alzheimer's Awareness

Alzheimer's Awareness

USA Chicago Alzheimer's Hispanic Families Telenovela
NeuroSense Drug Advances

NeuroSense Drug Advances

USA Cambridge Alzheimer's NeuroSense PrimeC
EEG Test for Alzheimer's

EEG Test for Alzheimer's

United Kingdom Alzheimer's Belfast Cumulus Neuroscience Fastball EEG
Leqembi Approval

Leqembi Approval

United States New York FDA Approval Leqembi Alzheimer's
Xanamem Trial Update

Xanamem Trial Update

Australia Sydney Alzheimer's Xanamem Actinogen
Cerecin and NIHR Team Up

Cerecin and NIHR Team Up

USA Denver Alzheimer's Cerecin NIHR HealthTech
Leqembi Launches in EU

Leqembi Launches in EU

Sweden Stockholm Leqembi BioArctic Alzheimer's
Selonterra's New Patent

Selonterra's New Patent

United States biotech San Mateo Alzheimer's Selonterra
Labcorp Alzheimer's Test

Labcorp Alzheimer's Test

USA Labcorp Alzheimer's Blood Test Burlington, North Carolina
LEQEMBI® Study Insights

LEQEMBI® Study Insights

United States Cambridge Lecanemab Leqembi Alzheimer's
LEQEMBI® Treatment Update

LEQEMBI® Treatment Update

Japan Tokyo Eisai Leqembi Alzheimer's
Alzheimer's Diagnostics

Alzheimer's Diagnostics

USA Rockville Alzheimer's TrilliumBiO T-NeuroDx
Creyos at AAIC 2025

Creyos at AAIC 2025

Canada Toronto Alzheimer's cognitive health Creyos
Advances in Alzheimer's Diagnostics

Advances in Alzheimer's Diagnostics

United States Alzheimer's Carlsbad ALZpath pTau217
Cumulus at AAIC 2025

Cumulus at AAIC 2025

Canada Toronto Alzheimer's Cumulus Neuroscience CNS-101
Donanemab Approved?

Donanemab Approved?

None Alzheimer's Eli Lilly Donanemab
Lecanemab Efficacy Data

Lecanemab Efficacy Data

Sweden Stockholm Lecanemab Eisai Alzheimer's
Kisunla FDA Approval

Kisunla FDA Approval

USA Indianapolis Alzheimer's Lilly Kisunla
Neuraceq® Approval

Neuraceq® Approval

USA FDA Approval Boston Alzheimer's Neuraceq®

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.